[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google

Genomics at FDA
Interdisciplinary Pharmacogenomics Review Group (IPRG)

About the IPRG

The mission of the Interdisciplinary Pharmacogenomics Review Group (IPRG) is to establish a scientific and regulatory framework for reviewing genomic data. The IPRG is an Agency-wide review group, whose members include individuals from CDER, CBER, CDRH, NCTR, OCP and CVM.

The IPRG is the primary review body for Voluntary Genomic Data Submissions (VGDS). Upon request, the IPRG also consults with FDA review staff on the review of required submissions, e.g., IND, NDA, BLA or IDE, containing genomic data.

Further information on the function and responsibilities of this group can be found in the document Management of the Interdisciplinary Pharmacogenomics Review Group (IPRG)”, MaPP 4180.2

Organization of the IPRG













Participants in IPRG

Avigan, Mark I
Becker, Robert
Catalano, Jennifer
Chan, Maria M
Dragan, Yvonne
Dunham, Bernadette M
Frueh, Felix
Fuscoe, James
Galson, Steven
Goodman, Jesse
Goodsaid, Federico

Gutman, Steve
Hackett, Joe
Hewlett, Indira
Huang, Shiew Mei
Jacobson-Kram, David
Kodell, Ralph
Kozlowski, Steven
Leighton, John K
Lesko, Lawrence J
Lightfoote, Marilyn
Meyer, Robert J
Murphy, Shirley
ONeill, Robert T
Puri, Raj K.
Rudman, Allen
Schultz, Daniel
Slikker, William
Sundlof, Stephen F
Temple, Robert
Throckmorton, Douglas C
Tiwari, Jawahar
Vishnuvajjala, R. Lakshmi
Wang, Sue Jane
Woodcock, Janet

Back to Top     Back to Genomics

Date created: March 22, 2005, updated October 25, 2005

horizonal rule